1. Amaducci, L., Crook, T.H., Lippi, A., Baldereschi, M., Latarraca, S., Piersanti, P., Tesco, G., and Sorbi, S. (1991) Use of Phosphatidylserine in Alzheimer’s Disease, Ann. New York Acad. Sci. 640, 245–249.
2. Crook, T.H., Petrie, W., Wells, C., and Massari, D.C. (1992) Effects of Phosphatidylserine in Alzheimer’s Disease, Psychopharmaco. Bulletin 28, 61–66.
3. Heiss, W.D., Kessler, J., Mielke, R., Szelies, B., and Herholz, K. (1994) Long-Term Effect of Phosphatidylserine, Phritinol and cognitive Training in Alzheimer’s Disease, Dementia 5, 88–98.
4. Gelbmann, C.M., and Muller, W.E. (1991) Chronic Treatment with Phosphatidylserine Restores Muscarinic Cholinergic Receptor Deficits in the Aged Mouse Brain, Neurobiol. Aging 13, 45–50.
5. Sambrano, G.B., and Steinberg, D. (1995) Recognition of Oxidatively Damaged and Apoptotic Cells by an Oxidized Low Density Lipoprotein Receptor on Mouse Peritoneal Macrophages: Role of Membrane Phosphatidylserine, Proc. Natl. Acad. Sci. USA 92, 1396–1400.